Peter Hendricks

Dr. Hendricks is a clinical psychologist, University Professor, and Heersink Endowed Chair of Psychiatry in the Department of Psychiatry and Behavioral Neurobiology at UAB. His research centers on the development of novel and potentially more effective treatments for substance use disorders and comorbid conditions, with specific areas of focus on vulnerable populations, including individuals in the criminal justice system. He completed the first ever study of psilocybin in the treatment of cocaine use disorder, and is currently Principal Investigator of pilot trials of psilocybin-facilitated psychotherapy in the treatment of fibromyalgia, and low doses or “microdoses” of psilocybin in the treatment of demoralization. Dr. Hendricks is site PI of a NIDA-funded study of psilocybin for smoking cessation and co-editor-in-chief of Psychedelic Medicine.